Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational phase III trial (TROPIC)

De Bono J. S., Oudard S., Ozguroglu M., Hansen S., Machiels J. H., Shen L., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.28, sa.15, 2010 (SCI-Expanded) identifier